Patients generally prefer oral medications versus injections due to ease of administration. For optimal efficacy, the drug must travel within the gastrointestinal tract to the site of action before being released. Thus, the Seeker is interested in an innovative energy source suitable for an ingestible drug delivery device.
This Theoretical Challenge requires only a written proposal.
There is a growing list of prescribed medications that are self-injectable drugs. Common barriers of medical adherence include injection concerns such as pain, aversion to needles, and inconvenience. To circumvent the need for self-injections, researchers are investigating new approaches for oral drug delivery. The Seeker is interested in a triggerable, energy release solution to support alternative drug delivery technologies.
This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker.
To receive an award, the Solvers will have to transfer their exclusive intellectual property (IP) rights to the Seeker. However, the Seeker will be willing to consider a licensing agreement for a partial award if exclusive IP cannot be transferred by the Solver.
Awards:- $ 25,000